The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors

Bhavina D.O. Batukbhai, Ana De Jesus-Acosta

Research output: Contribution to journalReview article

Abstract

Pancreatic neuroendocrine tumors are rare tumors of the pancreas originating from the islets of the Langerhans. These tumors comprise 1% to 3% of all newly diagnosed pancreatic cancers every year and have a unique heterogeneity in clinical presentation. Whole-genome sequencing has led to an increased understanding of the molecular biology of these tumors. In this review, we will summarize the current knowledge of the signaling pathways involved in the tumorigenesis of pancreatic neuroendocrine tumors as well as the major studies targeting these pathways at preclinical and clinical levels.

Original languageEnglish (US)
Pages (from-to)9-21
Number of pages13
JournalPancreas
Volume48
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Neuroendocrine Tumors
Neoplasms
Pancreatic Neoplasms
Islets of Langerhans
Molecular Biology
Pancreas
Carcinogenesis
Genome

Keywords

  • checkpoints
  • molecular biology
  • pancreatic neuroendocrine tumor
  • panNET
  • signaling pathways
  • tumorigenesis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors. / Batukbhai, Bhavina D.O.; De Jesus-Acosta, Ana.

In: Pancreas, Vol. 48, No. 1, 01.01.2019, p. 9-21.

Research output: Contribution to journalReview article

@article{2169834ad8444281ae57c3c6d5e1e501,
title = "The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors",
abstract = "Pancreatic neuroendocrine tumors are rare tumors of the pancreas originating from the islets of the Langerhans. These tumors comprise 1{\%} to 3{\%} of all newly diagnosed pancreatic cancers every year and have a unique heterogeneity in clinical presentation. Whole-genome sequencing has led to an increased understanding of the molecular biology of these tumors. In this review, we will summarize the current knowledge of the signaling pathways involved in the tumorigenesis of pancreatic neuroendocrine tumors as well as the major studies targeting these pathways at preclinical and clinical levels.",
keywords = "checkpoints, molecular biology, pancreatic neuroendocrine tumor, panNET, signaling pathways, tumorigenesis",
author = "Batukbhai, {Bhavina D.O.} and {De Jesus-Acosta}, Ana",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/MPA.0000000000001189",
language = "English (US)",
volume = "48",
pages = "9--21",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors

AU - Batukbhai, Bhavina D.O.

AU - De Jesus-Acosta, Ana

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pancreatic neuroendocrine tumors are rare tumors of the pancreas originating from the islets of the Langerhans. These tumors comprise 1% to 3% of all newly diagnosed pancreatic cancers every year and have a unique heterogeneity in clinical presentation. Whole-genome sequencing has led to an increased understanding of the molecular biology of these tumors. In this review, we will summarize the current knowledge of the signaling pathways involved in the tumorigenesis of pancreatic neuroendocrine tumors as well as the major studies targeting these pathways at preclinical and clinical levels.

AB - Pancreatic neuroendocrine tumors are rare tumors of the pancreas originating from the islets of the Langerhans. These tumors comprise 1% to 3% of all newly diagnosed pancreatic cancers every year and have a unique heterogeneity in clinical presentation. Whole-genome sequencing has led to an increased understanding of the molecular biology of these tumors. In this review, we will summarize the current knowledge of the signaling pathways involved in the tumorigenesis of pancreatic neuroendocrine tumors as well as the major studies targeting these pathways at preclinical and clinical levels.

KW - checkpoints

KW - molecular biology

KW - pancreatic neuroendocrine tumor

KW - panNET

KW - signaling pathways

KW - tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=85058612732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058612732&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001189

DO - 10.1097/MPA.0000000000001189

M3 - Review article

C2 - 30531241

AN - SCOPUS:85058612732

VL - 48

SP - 9

EP - 21

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 1

ER -